TNF and rheumatoid arthritis: Some of the basic science observations can be extended to RA, where Chou et al. (2010) observed that people with RA receiving TNF inhibitor treatment (infliximab, etanercept, adalimumab) showed a reduction in the risk of developing AD compared to controls (Chou et al., 2010).